6/6 – Références bibliographiquespearlweb2023-11-30T09:59:58+01:00

Références bibliographiques

 

• Références Atteintes kystiques :
  • Mikolajczyk AE et al. Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease. Clinical Gastroenterology and Hepatology 2017.
  • Butscher A et al. Atteintes extrarénales de la polykystose rénale: signes cliniques, dépistage et prise en charge. Rev Med Suisse 2017
  • Chauveau D et al. Liver Involvement in Autosomal-Dominant Polycystic Kidney Disease. J Am Soc Nephrol 2002
  • Alvaro D et al. Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol 2008
  • Torres VE et al. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease. New England J Med 2012
  • Farges O et al. Fenestration in the management of polycystic liver disease. World J Surg 1995
  • Drenth JP et al., Medical and surgical treatment options for polycystic liver disease. Hepatology 2010
  • Arrazola L et al. Model for end-stage liver disease (MELD) exception for polycystic liver disease. Liver Transplant 2006
  • Mancinelli et al. Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease. Lab Invest 2016
  • Suwabe T et al., Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials. Plos One 2021.Autres atteintes kystiques

• Autres atteintes kystiques
  • Torra R. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 1997
  • Schievink WI et al. Spinal meningeal diverticula in autosomal dominant polycystic kidney disease. Lancet 1997
  • Torra R et al. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2008

• Hemorragie intra kystique
  • Neuville M et al. Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney DIsease. Plos One 2016

-Suwabe T et al. Suitability of Patients with Autosomal Dominant Polycystic Kidney Disease for Renal Transcatheter Arterial Embolization. J Am Soc Nephrol 2016

• Infections de kystes
  • Bobot M et al. Diagnostic performance of [18F]fluorodeoxyglucose positron emission tomography–computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiology Injection. 2016
  • Sallée M et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2009
  • Neuville M et al. Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney DIsease. Plos One 2016

-Lantinga MA et al. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review. Nephrol Dial Transplant 2016

• Complications cardio-vasculaires
  • Schrier RW et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 2014
  • Chapman AB, et al. Hypertension in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 2010.
  • Kelleher CL, et al. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U. S. population. Am. J. Hypertens. 2004.
  • Gimpel C. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nat Rev Nephrol 2019
  • Qian Q et al. Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007

• Anévrysmes
  • Pirson Y et al. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002
  • Gambhir S et al. Clinical lessons and risk factors from 403 fatal cases of subarachnoid haemorrhage. J Clin Neurosci 2009
  • Perone RD et al. Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2016
  • Bouleti C et al. Risk of Ascending Aortic Aneurysm in Patients With Autosomal Dominant Polycystic Kidney Disease. Am J Cardiol 2019
  • Sanchis IM et al. Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol 2019
  • Malhotra A et al., MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis. Radiology 2019
  • Flahault A et al., Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective. Kidney Int 2019
  • Lefèvre S et al., Diagnosis and Risk Factors for Intracranial Aneurysms in Autosomal Polycystic Kidney Disease: A cross-sectional study from the Genkyst Cohort. Nephrol Dial Transplant 2022

• Valvulopathies
  • Hossack KF et al. Echocardiographic findings in autosomal dominant polycystic kidney disease.N Engl J Med1988
• Autres atteintes
  • Pavik I et al. Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate. Kidney Int 2011
  • Chonchol et al. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease Clin J Am Soc Nephrol 2017
  • Morris-Stiff G et al. Abdominal wall hernia in autosomal dominant polycystic kidney disease. Br J Surg 1997
  • Luciano RL et al. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 2013
  • Driscoll JA et al. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest 2008
  • Torra R et al. Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2008